-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Anavex Life Sciences Corp. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q3 2014 to Q3 2025.
- Anavex Life Sciences Corp. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Sep 2025 was $54.8M, a 13.7% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)